Datamonitor's OTC Pharmaceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of OTC Pharmaceuticals in the United States's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of OTC Pharmaceuticals in the United States
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by both value and volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Market shares are covered by manufacturer and/or brand
Also features market breakdown by distribution channel

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purpose of this report the Americas comprises Argentina, Brazil, Canada, Chile, Colombia, Mexico, Venezuela, and the US.

Executive Summary
Market Overview
- Market Definition
- Research Highlights
- Market Analysis
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
- Summary
- Buyer Power
- Supplier Power
- New Entrants
- Substitutes
- Rivalry
Leading Companies
- Johnson & Johnson
- Pfizer
- Procter & Gamble Company, The
Market Distribution
Market Forecasts
- Market Value Forecast
Macroeconomic Indicators
Appendix
- Methodology
- Industry Associations
- Related Datamonitor Research
- Disclaimer
About Datamonitor
- Premium Reports
- Summary Reports
- Datamonitor Consulting
List of Tables
- Table 1: United States Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Table 2: United States Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Table 3: United States Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Table 4: United States Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Table 5: Johnson & Johnson: Key Facts
- Table 6: Johnson & Johnson: Key Financials ($)
- Table 7: Johnson & Johnson: Key Financial Ratios
- Table 8: Pfizer: Key Facts
- Table 9: Pfizer: Key Financials ($)
- Table 10: Pfizer: Key Financial Ratios
- Table 11: Procter & Gamble Company, The: Key Facts
- Table 12: Procter & Gamble Company, The: Key Financials ($)
- Table 13: Procter & Gamble Company, The: Key Financial Ratios
- Table 14: United States Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Table 15: United States Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
- Table 16: United States Size of Population (Million), 2005-09
- Table 17: United States Gdp (Constant 2000 Prices, $ Billion), 2005-09
- Table 18: United States Gdp (Current Prices, $ Billion), 2005-09
- Table 19: United States Inflation, 2005-09
- Table 20: United States Consumer Price Index (Absolute), 2005-09
- Table 21: United States Exchange Rate, 2005-09
List of Figures
- Figure 1: United States Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Figure 2: United States Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Figure 3: United States Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Figure 4: United States Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Figure 5: Forces Driving Competition in The Otc Pharmaceuticals Market in The United States, 2009
- Figure 6: Drivers of Buyer Power in The Otc Pharmaceuticals Market in The United States, 2009
- Figure 7: Drivers of Supplier Power in The Otc Pharmaceuticals Market in The United States, 2009
- Figure 8: Factors Influencing The Likelihood of New Entrants in The Otc Pharmaceuticals Market in The United States, 2009
- Figure 9: Factors Influencing The Threat of Substitutes in The Otc Pharmaceuticals Market in The United States, 2009
- Figure 10: Drivers of Degree of Rivalry in The Otc Pharmaceuticals Market in The United States, 2009
- Figure 11: Johnson & Johnson: Revenues & Profitability
- Figure 12: Johnson & Johnson: Assets & Liabilities
- Figure 13: Pfizer: Revenues & Profitability
- Figure 14: Pfizer: Assets & Liabilities
- Figure 15: Procter & Gamble Company, The: Revenues & Profitability
- Figure 16: Procter & Gamble Company, The: Assets & Liabilities
- Figure 17: United States Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Figure 18: United States Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14

Pharmaceutical Market Research

OTC Pharmaceuticals in the United States